Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexpanthenol cream for prevention of pregnancy stretch marks in first-time pregnant women
IRCT20240809062706N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexpanthenol in striae gravidarum (SG) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Incidence of striae gravidarum. Started Dec 2024; status: completed.
02
Drugs
dexpanthenol
03
Conditions
striae gravidarum (SG)
Beyond the preview
Go deeper on IRCT20240809062706N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240809062706N2.